Journey towards traceability implementation
Jordan announced the implementation of pharma serialization in 2017. The first phase included a transition period during which 2D DataMatrix codes were allowed for secondary packaging. It is important to note that serialization was not yet mandatory during this period lasting for a whole year until June 2018. The next phase focused on the implementation of serialization specifically for 2D codes. The aim was to have the entire Jordanian Track & Trace system fully operational by the beginning of 2020.
Nonetheless, the Serialization of secondary packaging on regulated pharmaceutical products deadline in Jordan was postponed several times by JFDA.
JFDA published a new circular extending the implementation deadline for 2D Data Matrix and serialization on secondary packaging on regulated pharmaceutical products until 31 March 2024.
Current track and trace requirements
The JFDA has established specific requirements for product labelling and packaging to ensure consumer safety and information transparency. The requirements for pharma serialization in Jordan are based on GS1 standards.
In general, the barcode must contain the following information:
- Global Trade Item Number (GTIN)
- Serial Number (SN)
- Batch/ Lot number
- Expiry date
The human-readable part must include the same elements, as the manufacturing data (MFD) and National Healthcare Reimbursement Number (NHRN) are optional.
Products that require barcoding
All human drugs, veterinary drugs and herbal and health products. intended to be placed on the Saudi market require barcoding according to the SFDA guideline. Exceptions are made only for:
- Free samples;
- Non-registered drugs ordered for specific patients;
- Drugs cleared for personal use;
- Drugs that must be repackaged – non-finished products.